Background An understanding of the relationship between patient factors and healthcare resource utilization represents a major point of interest for optimizing clinical care and overall net savings, yet maintaining financial margins for provider revenues. This study aims to review resource utilization after cholecystectomy in order to characterize patient factors associated with increased postoperative ED visits and 30-day readmissions. Methods A total of 53,632 open and laparoscopic cholecystectomies were reviewed from July 2009 to December 2010 in a large private payer claims database. ICD-9 and CPT codes were available for each event, as well as basic demographics. Data regarding 30-day postoperative resource utilization metrics (emergency department visits and inpatient hospitalizations) were analyzed and stratified by key patient comorbidities. Differences between subgroups were evaluated with univariate and multivariable methods. Results Of the 53,632 patients studied, 71.2 % (38,171) were female and 28.8 % (15,461) male. Resource utilization within 30 days of surgery included: 6.6 % (3538) of patients with an ED visit and 7.7 % (4103) with an inpatient hospitalization. The most common comorbidities in the study population were: hypertension, hyperlipidemia, GERD/hiatal hernia, and diabetes mellitus. Patients with heart failure, cirrhosis, and a history of MI or acute ischemic heart disease all had a significant association with postoperative ED visit and the highest likelihood of inpatient hospitalization. Angina, diabetes, and hypertension similarly increased both ED utilization and inpatient readmissions to a lesser but still significant extent. Although patients with GERD/hiatal hernia and sleep apnea had a significant association with ED use, they did not have an increased likelihood of readmission. Conclusions Patient comorbidity indexing plays a major role in clinical risk stratification and resource utilization for cholecystectomy. These factors should be considered in bundled reimbursement packages and in the creation of preventive postoperative ambulatory strategies given their role in determining potential resource utilization in the postoperative setting.
comorbidities may play a significant role in the total cost of care. Injury to the common bile duct is well known as a major contributor to cost and resource utilization, with immediate associated costs ranging from $13,612 to $30,000 and lifetime costs reported as high as $300,000 [4] [5] [6] [7] . In addition, various patient, hospital, and surgeon factors-such as age, sex, presence of comorbidities, urgency of admission and surgery, length of stay (LOS), treatment in a regional or district hospital, hospital volume, and surgeon experience [8] [9] [10] [11] [12] [13] [14] [15] -have been shown to affect cholecystectomy outcomes and associated overall resource use and costs.
The USA has become increasingly cost-conscious in an era of rising and unsustainable healthcare costs. The commencement of the Affordable Care Act (ACA) has triggered a closer look at healthcare spending with the aim to decrease inefficiencies and increase the value and quality of care that patients receive. A deeper and more thorough understanding of healthcare resource utilization is vital for the creation and implementation of new payment approaches, such as bundled payments and accountable care models, intended to reduce waste and create valuable, affordable health care [16] . Prior studies have evinced the influence of patient comorbidities on the utilization of resources such as office visits, emergency department (ED) visits, length of stay, drug costs, procedures, and overall costs in other study populations [17] [18] [19] [20] [21] . Vertees et al. [22] found that a patient's chronic disease burden may be more predictive of a patient's resource use than the acute disease burden. Given the knowledge of how patient factors influence resource utilization in other conditions and the current healthcare movement toward innovative reimbursement models, this study serves to elucidate the impact of patient comorbidities on resource utilization after cholecystectomy. Quantification of these impacts may be useful for guiding the development of risk-stratified, casemix appropriate bundled reimbursement packages for cholecystectomy.
Materials and methods
This was a retrospective observational cohort study of privately insured patients undergoing cholecystectomy in which predictor variables were defined by the presence or absence of various chronic comorbid conditions. Approval from the Cambridge Health Alliance Institutional Review Board (IRB) was obtained.
Study design
This study was a retrospective cohort study utilizing a private payer claims database (Aetna, Inc., Hartford, CT). Inclusion criteria consisted of age C16 years, a record of cholecystectomy between July 1, 2009, and December 31, 2010, and enrollment in the health plan for at least 6 months before and 3 months after the cholecystectomy to stabilize the comorbidity database and allow tracking of consecutive health events and resource use. Claims records were stripped of protected health information by Aetna personnel not involved in this study to produce the HIPAAcompliant de-identified dataset used in this analysis. Cholecystectomy procedures were identified by the International Classification of Diseases, Ninth Revision (ICD-9) or Current Procedural Terminology (CPT) codes listed in the 'Appendix 1.'
Outcome measures
Data regarding 30-day postoperative resource utilization were stratified and analyzed by patient comorbidities. The comorbid conditions that were studied include hypertension, hyperlipidemia, GERD/hiatal hernia, diabetes mellitus, angina/chronic ischemic heart disease (IHD), sleep apnea, heart failure, myocardial infarction (MI)/acute IHD, hypertensive heart disease, and cirrhosis of the liver or bile ducts. These conditions were defined by the presence of an associated ICD-9 code within the 6-month period immediately prior to the cholecystectomy.
The endpoints in this study were 30-day emergency department (ED) visits, 30-day readmissions, and length of stay for the 30-day readmissions. A readmission was defined as utilization classified as inpatient in the source data. Length of stay was calculated as discharge date minus admission date.
Statistical analyses
Descriptive statistics were used to summarize baseline patient characteristics, including demographics and comorbid conditions. Outcomes were summarized for the overall population and by subgroups with and without each comorbid condition. Pearson's Chi-squared p values were calculated to evaluate the statistical significance of all differences in outcomes between cohorts. No adjustments were made to these p values to account for multiple comparisons.
Logistic regression was utilized to determine the impact of baseline comorbid conditions on 30-day readmission rates, while adjusting for demographic differences.
Stepwise selection was used to choose the statistically significant predictor variables from among all studied comorbid conditions, age, gender, and region. Sensitivity regression models were also run for the subsets of readmissions including and not including an overnight stay. All statistical analyses were conducted using SAS version 9.2 (SAS Institute, Cary, NC).
Results
A total of 53,632 patients were included in this study: 71.2 % (38,171) were female and 28.8 % (15,461) male. Baseline patient characteristics are given in Table 1 . Of all cholecystectomies studied, 94.9 % (50,900) were laparoscopic, 63.9 % (34,285) were outpatient procedures, and 51.2 % (27,439) occurred in the south (US Census Region 3) of the USA. The prevalence of chronic comorbidities seen in the study population is reported in Table 2 Table 3 ). The top three diagnoses recorded during the inpatient readmissions were abdominal pain at an unspecified site, chest pain not otherwise specified (NOS), and abdominal pain in the right upper quadrant (RUQ) at 7.6 % (700), 2.4 % (223), and 2.4 % (217), respectively (Table 4) . ED visits were not significantly different across sexes, but inpatient hospitalizations were, with males comprising a greater proportion of readmitted patients (9.9 % males vs. 6.8 % females, p \ 0.0001) ( Table 5 ). Resource utilization within 30 days of cholecystectomy, stratified by comorbid conditions, is given in Table 6 . All of the comorbidities studied, except for hyperlipidemia and hypertensive heart disease, had a significantly increased postoperative ED utilization.
Odds ratios and 95 % Wald confidence limits for the effect of baseline comorbidities on 30-day readmission are given in Table 7 . All studied comorbid conditions except GERD and sleep apnea were statistically significant predictors of 30-day readmission. Of the remaining baseline comorbidities, all resulted in increased risk of readmission except for hyperlipidemia, which showed a slightly reduced risk after adjusting for all other predictors [odds ratio (OR) = 0.867, CI 0.801-0.938, p = 0.0004]. Comorbid conditions that significantly increased the odds of a 30-day readmission included both acute and chronic IHD, cirrhosis of the liver or bile ducts, diabetes, heart failure, hypertension, and hypertensive heart disease. Age also had a highly significant impact on 30-day readmission, with OR estimates increasing from 0.993 for ages 35-44 to 4.277 for ages 75 and older. Gender and region had modest but statistically significant impacts on 30-day readmission, 1 Lengths of stay were calculated by subtracting discharge date from admission date. LOS of 0 days informs that the admission and discharge date were the same, suggesting discharge from the hospital before midnight on the same day as admission.
with females at lower risk than males and patients in the south having the lowest regional risk compared to patients in the Midwest with the highest risk of readmission.
Discussion
The relationship between comorbidities and postoperative resource use after cholecystectomy has been poorly defined in the literature. Some reports relating comorbidities and/or complications to cost exist [3, 4, 8, 9] , but a greater understanding of comorbidity impact on the utilization of specific resources is needed in order to guide the creation of evidence-based payment models with global reimbursements focused on clearly defined packages of patientcentered and risk-stratified post-discharge resources in the postoperative setting after cholecystectomy. On January 31, 2013, the Centers for Medicare and Medicaid Services (CMS) announced the healthcare organizations selected to participate in the Bundled Payments for Care Improvement (BPCI) initiative [23] . Based on the Medicare severity diagnosis-related group (MS-DRG), bundled payments in the BPCI initiative encourage the use of risk adjustment which allows for increased payments to compensate for the higher costs of treating more severely ill patients. The higher cost of treating sicker patients does not solely correlate with the acute disease burden represented by the MS-DRG; however, chronic disease burden significantly impacts a patient's total cost of care and may in fact play a greater role in resource utilization than acute disease burden [22] . Hughes et al. [24] showed the predictive power of integrating the chronic disease burden of patient comorbidities into a system of risk categories in order to stratify patients by their expected use of healthcare resources in a future year. This paper is intended to define the relationship that exists between patient comorbidities and postoperative utilization of resources in terms of distinct visits after laparoscopic and open cholecystectomy. Patients with heart failure were the most likely of all to visit to the ED and to [3] . Therefore, it is prudent to note the influence of the comorbidities that increase readmission rates and inpatient LOS after cholecystectomy in addition to those that increase ED utilization. Hyperlipidemia did not increase ED utilization and was a negative predictor of inpatient readmissions in this study population. This may reflect a population of otherwise healthy patients presenting with a 'laboratory comorbidity' as defined by strict numbers yet without any type of actual visceral organ disease. These data demonstrate how two patients with similar costs but different chronic conditions lead to different utilization of resources after surgery: a patient with GERD who visits the ED repeatedly for reflux symptoms and pain Predictors that were not statistically significant: GERD and sleep apnea in the postoperative setting versus a patient with cirrhosis and heart failure requiring a prolonged inpatient hospitalization postoperatively due to fluid shifts and heart failure exacerbation after intraoperative fluid resuscitation. Although these patients may be very similar in a strictly monetary sense, their use of hospital resources is vastly different. An understanding of the specifics of resource utilization by patient comorbidity would allow for appropriate departmental reimbursements by insurance companies as well as the creation of strategies targeted at improving the efficiency of resource use and distribution by hospital administration. In this analysis, not every comorbidity that increased utilization of ED resources led to increased readmission rates. The two comorbidities that were associated with an increased likelihood of ED visit that did not lead to inpatient readmissions were GERD/ hiatal hernia and sleep apnea. Similarly, the impact of resource use will vary from organization to organization based upon the characteristics of their patient population. The knowledge gained from this study can be used to create ambulatory strategies to prevent exacerbation of existing patient comorbidities in the perioperative setting and thereby decrease costly postoperative resource utilization. Examples of these strategies might include followup telephone calls, home ambulatory services such as Visiting Nurse Association (VNA) visits, and close outpatient follow-up with primary care providers. These services could not only lead to less ED visits and inpatient hospitalizations, but also result in better coordination of care, create greater value of services received for patients, and yield lower overall costs to the healthcare system. Past successes in bundled payment models exist, a prime example of which is Geisinger Health System's ProvenCare initiative for coronary artery bypass grafting [25] . However, reimbursements for surgical procedures are decreasing in the face of increasing productivity and governmental regulations. Over the past 15 years, reimbursement has decreased by 2.9 % for cholecystectomies [26] . At present-day Medicaid reimbursement rates, Frazee et al.'s analysis [27] defines the 'break-even point' for laparoscopic cholecystectomy at 454 cases-this presents a major financial limitation to lower-volume centers performing this operation and therefore may negatively impact access to care. Analysis of the comorbid conditions in a particular healthcare group's coverage will aid in the projection of resource utilization and subsequent administrative planning for cholecystectomy. Such preparation will enable various processes: opportunities for the creation of preventive strategies, optimization of healthcare delivery, and appropriate distribution of reimbursement profiles to enable increased profit margins for providers, in the context of risk-adjusted reimbursements from payers.
Limitations
Despite the advantages of using a large private payer database for studying postoperative resource utilization after cholecystectomy, there are several limitations to this approach. The major limitations relate to the use of claims data, namely that we must use ICD-9 diagnosis codes to determine patient comorbid conditions and that the study population is not nationally representative. The data source used in this study only included subscribers to a single private insurance provider and did not include the uninsured population. Using ICD-9 codes to determine comorbidities can lead to underrepresentation of the conditions in the study population, though coding of chronic conditions tends to be much more complete at the time of hospitalization and/or surgical intervention. Although the comprehensive nature of patient utilization captured in claims data is helpful for elucidating 30-day postoperative resource utilization, it likely overestimates the use of resources associated with cholecystectomy, as the etiology of the visit or hospitalization could be another, unrelated source.
Obesity is known to both correlate with and contribute to the pathophysiology of many of the conditions associated with increased utilization of resources in this study, such as hypertension, hyperlipidemia, GERD and hiatal hernia, diabetes mellitus, heart disease, sleep apnea, and heart failure [28] . The multivariate analyses we conducted allowed for the evaluation of each risk factor independently of the other but did not allow for the evaluation of the effects of obesity, a variable excluded from the study due to severe underreporting of obesity codes. Martin et al.'s Canadian study [29] revealed that a diagnosis of obesity had a sensitivity of a mere 7.75 % in their database of 17,380 patients; similarly, Januel et al. [30] show the scanty sensitivity of obesity coding in Switzerland (ranging from 29.4 % in 1999 to 51.5 % in 2003). These studies convey the extent to which obesity is underreported in administrative databases. Therefore, it was not possible to determine the resultant effect of obesity on postoperative resource utilization in this study. In accordance with the ACA mandate that healthcare claims data be used extensively to assess resource utilization and quality of care starting in 2015 [31] , it is inevitable that large payer and other administrative databases will be increasingly used to evaluate healthcare systems in the near future. In order for authorities involved in all aspects of healthcare to draw accurate conclusions from these databases, more precise coding information regarding obesity needs to be included. Rao et al. [32] demonstrated that dialysis-dependent patients with end-stage renal disease had an increased risk of a number of postoperative complications after laparoscopic cholecystectomy which led to increased mean length of stay in the hospital. Due to the low number of patients with renal failure in the study cohort, however, this condition was not included in the analysis.
Conclusion
This study showed that certain comorbid conditions significantly increase utilization of postoperative resources in terms of ED visits and inpatient readmissions. In particular, heart failure, cirrhosis, and a history of MI/acute ischemic heart disease were not only significantly associated with increased ED utilization but also had the highest likelihood of inpatient readmission. Further investigation may identify the causality of these relationships and lead to the development of preventive strategies. Such an approach has the potential to not only decrease unnecessary visits, but also improve the quality of patient care and maintain provider profit margins in the face of decreasing reimbursements for surgical procedures. These factors should be considered in bundled reimbursement packages given their role in determining potential resource utilization in the postoperative setting.
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